ReviewAnnals of the rheumatic diseases1999
Tumour necrosis factor and other cytokines in murine lupus.
Review in Annals of the rheumatic diseases, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A functional M196R polymorphism of tumour necrosis factor receptor type 2 is associated with systemic lupus erythematosus: a case-control study and a meta-analysis.Annals of the rheumatic diseases · 2007Pooled it
- Caspase-8-dependent control of NK- and T cell responses during cytomegalovirus infection.Medical microbiology and immunology · 2019Review
- Adoptive transfer of autoimmune splenic dendritic cells to lupus-prone mice triggers a B lymphocyte humoral response.Immunologic research · 2017Article
- MicroRNA-let-7a expression is increased in the mesangial cells of NZB/W mice and increases IL-6 production in vitro.Autoimmunity · 2013Article
- Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.Clinical rheumatology · 2013Review
- Novel treatments for systemic lupus erythematosus.Therapeutic advances in musculoskeletal disease · 2011Article
- Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.Arthritis and rheumatism · 2011Article
- A new model of induced experimental systemic lupus erythematosus (SLE) in pigs and its amelioration by treatment with a tolerogenic peptide.Journal of clinical immunology · 2010Article
- Article
- A novel transcript of mouse interleukin-20 receptor acts on glomerular mesangial cells as an aggravating factor in lupus nephritis.Genes and immunity · 2008Article
- The role of tumor necrosis factor-alpha in systemic lupus erythematosus.Arthritis research & therapy · 2008Review
- Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.Journal of immunology (Baltimore, Md. : 1950) · 2007Article
- Susceptibility of T cell receptor-alpha chain knock-out mice to ultraviolet B light and fluorouracil: a novel model for drug-induced cutaneous lupus erythematosus.Clinical and experimental immunology · 2004Article
- Enhanced expression of interferon-inducible protein 10 associated with Th1 profiles of chemokine receptor in autoimmune pulmonary inflammation of MRL/lpr mice.Arthritis research & therapy · 2004Article
- Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis.Journal of immunology (Baltimore, Md. : 1950) · 2003Article
- Dendritic cells infected with adenovirus expressing the thyrotrophin receptor induce Graves' hyperthyroidism in BALB/c mice.Clinical and experimental immunology · 2003Article
- SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus.Arthritis research & therapy · 2003Article
- Article
- Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus.Clinical and experimental immunology · 2002Article
- Aberrant high expression of B lymphocyte chemokine (BLC/CXCL13) by C11b+CD11c+ dendritic cells in murine lupus and preferential chemotaxis of B1 cells towards BLC.The Journal of experimental medicine · 2001Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.